Annual report pursuant to Section 13 and 15(d)

Equity-Based Compensation

v2.4.0.6
Equity-Based Compensation
12 Months Ended
Dec. 29, 2012
Equity-Based Compensation [Abstract]  
Equity-Based Compensation

NOTE K – EQUITY-BASED COMPENSATION

     Equity-based compensation expense for fiscal years 2010, 2011, and 2012 was $10,406, $10,549, and $10,210, respectively. The related tax benefit for these periods was $3,992, $3,852, and $3,554, respectively.

     The following table shows the remaining unrecognized compensation expense on a pre-tax basis for all types of unvested equity awards outstanding as of December 29, 2012. This table does not include an estimate for future grants that may be issued.

2013 $ 7,637
2014   5,682
2015   3,775
2016   1,735
2017   802
  $ 19,631

 

The cost above is expected to be recognized over a weighted-average period of 2.0 years.

     The Company's 2006 Equity Incentive Award Plan (the "2006 Plan") is currently the only plan under which equity awards are issued. This plan allows for the grant of various equity awards, including stock-settled stock appreciation rights, stock options, deferred stock units, and other types of equity-based awards, to the Company's officers, key employees, and non-employee directors.

     Since its inception 10,000 shares have been authorized under the 2006 Plan. As of December 29, 2012, a total of 5,829 awards had been granted under the 2006 Plan, of which 5,707 were stock-settled stock appreciation rights, 8 were stock options, and 114 were deferred stock units. Also, as of December 29, 2012, a total of 945 awards had been canceled and added back to the number of units available for issuance under the 2006 Plan.

     The Company's Compensation Committee utilizes two types of vesting methods when granting awards to officers and key employees under the 2006 Plan based upon the nature of the grant. Awards granted to officers and key employees upon hire or promotion to such a position will generally vest 20% each year on the anniversary of the grant date and expire five to five and one-half years from the date of grant. Awards granted as a supplement to existing equity awards held by officers and key employees will generally vest 50% on each of the fourth and fifth anniversary of the grant date and expire five and one-half years from the date of grant. Awards of stock options and stock-settled stock appreciation rights to be granted to non-employee directors will generally vest 25% each quarter, commencing on the last day of the fiscal quarter in which the awards are granted, and will expire five years to five and one-half years from the date of grant. Awards of deferred stock units are full-value shares at the date of grant, vesting over the periods of service, and do not have expiration dates.

     The Company uses the Black-Scholes option pricing model to estimate the fair value of its equity awards. The weighted-average fair value of stock-settled stock appreciation rights that were granted in 2010, 2011, and 2012, was $17.09, $12.40, and $15.35, respectively. Following is a table that includes the weighted-average assumptions that the Company used to calculate fair value of equity awards that were granted during the periods indicated. Deferred stock units are full-value shares at the date of grant and have been excluded from the table below.

          Year Ended        
    2010     2011     2012  
 
Expected volatility (1)   54.9 %   56.0 %   50.7 %
Risk-free interest rate (2)   1.7 %   1.1 %   0.6 %
Expected life (3)   4.2 yrs.   3.9 yrs.   3.9 yrs.
Expected dividend yield (4)   0.0 %   0.0 %   0.0 %
Weighted-average grant price (5) $ 38.28   $ 28.89   $ 39.41  

 

(1) Through June, 2012 expected volatility was a weighted-average of historical volatility and implied volatility. In July 2012, the Company eliminated the implied volatility aspect of this calculation and began utilizing historical volatility alone due to the lack of sufficient compliant option trading volume.

(2) Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.

(3) For awards that follow the 20% per year vesting schedule, expected life is a weighted-average that includes historical settlement data of the Company's equity awards and a hypothetical holding period for outstanding awards. Due to lack of historical settlement data on awards that follow the 50% vesting at each of years four and five, expected life of these awards is calculated under the simplified method.

(4) The Company historically has not paid dividends.

(5) Grant price is the closing price of the Company's common stock on the date of grant.

A summary of the Company's stock option and stock-settled stock appreciation right activity is as follows:

        Weighted- Weighted-average   Aggregate
        average grant remaining   intrinsic
  Shares     price contractual term   value*
Outstanding at December 31, 2011 3,808   $ 32.12 2.9 $ 8,603
Granted 387     39.41      
Exercised (1,397 )   29.16      
Canceled (65 )   29.95      
Expired (44 )   51.39      
 
Outstanding at December 29, 2012 2,689   $ 34.43 2.9 $ 5,136
 
Exercisable at December 29, 2012 774   $ 36.10 2.4 $ 1,275

 

* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company's common stock on the last trading day of the period) and the exercise price of awards that were in-the-money. The closing price of the Company's common stock at December 31, 2011 and December 29, 2012, was $30.37 and $31.60, respectively.

     The total intrinsic value of stock options and stock-settled stock appreciation rights exercised was $16,977 in 2010, $925 in 2011, and $20,590 in 2012.

A summary of the Company's deferred stock unit activity for 2012 is as follows:

        Weighted-
        average fair
  Shares     value
Nonvested at December 31, 2011 49   $ 44.29
Granted -     -
Vested (49 )   44.29
Canceled        
Expired -     -
Nonvested at December 29, 2012 -   $ -

 

     The total fair value of equity awards that vested during fiscal years 2010, 2011, and 2012 was $7,835, $10,993, and $10,211 respectively. This total fair value includes equity-based awards issued in the form of stock options, stock-settled stock appreciation rights, and deferred stock units.